B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial
- PMID: 20688574
- DOI: 10.1016/S1474-4422(10)70187-3
B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial
Abstract
Background: Epidemiological studies suggest that raised plasma concentrations of total homocysteine might be a risk factor for major vascular events. Whether lowering total homocysteine with B vitamins prevents major vascular events in patients with previous stroke or transient ischaemic attack is unknown. We aimed to assess whether the addition of once-daily supplements of B vitamins to usual medical care would lower total homocysteine and reduce the combined incidence of non-fatal stroke, non-fatal myocardial infarction, and death attributable to vascular causes in patients with recent stroke or transient ischaemic attack of the brain or eye.
Methods: In this randomised, double-blind, parallel, placebo-controlled trial, we assigned patients with recent stroke or transient ischaemic attack (within the past 7 months) from 123 medical centres in 20 countries to receive one tablet daily of placebo or B vitamins (2 mg folic acid, 25 mg vitamin B6, and 0.5 mg vitamin B12). Patients were randomly allocated by means of a central 24-h telephone service or an interactive website, and allocation was by use of random permuted blocks stratified by hospital. Participants, clinicians, carers, and investigators who assessed outcomes were masked to the assigned intervention. The primary endpoint was the composite of stroke, myocardial infarction, or vascular death. All patients randomly allocated to a group were included in the analysis of the primary endpoint. This trial is registered with ClinicalTrials.gov, NCT00097669, and Current Controlled Trials, ISRCTN74743444.
Findings: Between Nov 19, 1998, and Dec 31, 2008, 8164 patients were randomly assigned to receive B vitamins (n=4089) or placebo (n=4075). Patients were followed up for a median duration of 3.4 years (IQR 2.0-5.5). 616 (15%) patients assigned to B vitamins and 678 (17%) assigned to placebo reached the primary endpoint (risk ratio [RR] 0.91, 95% CI 0.82 to 1.00, p=0.05; absolute risk reduction 1.56%, -0.01 to 3.16). There were no unexpected serious adverse reactions and no significant differences in common adverse effects between the treatment groups.
Interpretation: Daily administration of folic acid, vitamin B6, and vitamin B12 to patients with recent stroke or transient ischaemic attack was safe but did not seem to be more effective than placebo in reducing the incidence of major vascular events. These results do not support the use of B vitamins to prevent recurrent stroke. The results of ongoing trials and an individual patient data meta-analysis will add statistical power and precision to present estimates of the effect of B vitamins.
Funding: Australia National Health and Medical Research Council, UK Medical Research Council, Singapore Biomedical Research Council, Singapore National Medical Research Council, Australia National Heart Foundation, Royal Perth Hospital Medical Research Foundation, and Health Department of Western Australia.
Copyright 2010 Elsevier Ltd. All rights reserved.
Comment in
-
Vitamin B supplements for prevention of stroke.Lancet Neurol. 2010 Sep;9(9):842-3. doi: 10.1016/S1474-4422(10)70188-5. Epub 2010 Aug 3. Lancet Neurol. 2010. PMID: 20688573 No abstract available.
-
Failure of vitamin supplementation to lower the risk of recurrent stroke.Curr Neurol Neurosci Rep. 2011 Feb;11(1):1-5. doi: 10.1007/s11910-010-0152-0. Curr Neurol Neurosci Rep. 2011. PMID: 20963642 No abstract available.
-
ACP Journal Club. B-vitamin supplements did not reduce vascular events in patients with recent stroke or TIA.Ann Intern Med. 2011 Feb 15;154(4):JC2-8. doi: 10.7326/0003-4819-154-4-201102150-02008. Ann Intern Med. 2011. PMID: 21320935 No abstract available.
Similar articles
-
Antiplatelet therapy and the effects of B vitamins in patients with previous stroke or transient ischaemic attack: a post-hoc subanalysis of VITATOPS, a randomised, placebo-controlled trial.Lancet Neurol. 2012 Jun;11(6):512-20. doi: 10.1016/S1474-4422(12)70091-1. Epub 2012 May 2. Lancet Neurol. 2012. PMID: 22554931 Free PMC article. Clinical Trial.
-
VITATOPS, the VITAmins TO prevent stroke trial: rationale and design of a randomised trial of B-vitamin therapy in patients with recent transient ischaemic attack or stroke (NCT00097669) (ISRCTN74743444).Int J Stroke. 2007 May;2(2):144-50. doi: 10.1111/j.1747-4949.2007.00111.x. Int J Stroke. 2007. PMID: 18705976 Clinical Trial.
-
Effect of B vitamins and lowering homocysteine on cognitive impairment in patients with previous stroke or transient ischemic attack: a prespecified secondary analysis of a randomized, placebo-controlled trial and meta-analysis.Stroke. 2013 Aug;44(8):2232-9. doi: 10.1161/STROKEAHA.113.001886. Epub 2013 Jun 13. Stroke. 2013. PMID: 23765945 Clinical Trial.
-
The VITATOPS (Vitamins to Prevent Stroke) Trial: rationale and design of an international, large, simple, randomised trial of homocysteine-lowering multivitamin therapy in patients with recent transient ischaemic attack or stroke.Cerebrovasc Dis. 2002;13(2):120-6. doi: 10.1159/000047761. Cerebrovasc Dis. 2002. PMID: 11867886 Review.
-
The effect of long-term homocysteine-lowering on carotid intima-media thickness and flow-mediated vasodilation in stroke patients: a randomized controlled trial and meta-analysis.BMC Cardiovasc Disord. 2008 Sep 20;8:24. doi: 10.1186/1471-2261-8-24. BMC Cardiovasc Disord. 2008. PMID: 18803866 Free PMC article. Review.
Cited by
-
Differential effect of ticagrelor versus clopidogrel by homocysteine levels on risk of recurrent stroke: a post hoc analysis of the CHANCE-2 trial.CMAJ. 2024 Feb 11;196(5):E149-E156. doi: 10.1503/cmaj.231262. CMAJ. 2024. PMID: 38346785 Free PMC article. Clinical Trial.
-
Prevalence and predictors of low folate levels among stroke survivors in a country without mandatory folate food fortification: Analysis of a Ghanaian sample.J Stroke Cerebrovasc Dis. 2023 Sep;32(9):107239. doi: 10.1016/j.jstrokecerebrovasdis.2023.107239. Epub 2023 Jul 20. J Stroke Cerebrovasc Dis. 2023. PMID: 37480805
-
Essential nutrients and cerebral small vessel diseases: a two-sample Mendelian randomization study.Front Nutr. 2023 Jun 22;10:1172587. doi: 10.3389/fnut.2023.1172587. eCollection 2023. Front Nutr. 2023. PMID: 37426181 Free PMC article.
-
The gastrointestinal-brain-microbiota axis: a promising therapeutic target for ischemic stroke.Front Immunol. 2023 Jun 2;14:1141387. doi: 10.3389/fimmu.2023.1141387. eCollection 2023. Front Immunol. 2023. PMID: 37342335 Free PMC article. Review.
-
The role of homocysteine levels as a risk factor of ischemic stroke events: a systematic review and meta-analysis.Front Neurol. 2023 May 12;14:1144584. doi: 10.3389/fneur.2023.1144584. eCollection 2023. Front Neurol. 2023. PMID: 37251231 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous